zonisamide has been researched along with Neurodegenerative Diseases in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, A | 1 |
| Sugumaran, R | 1 |
| Narayan, SK | 1 |
1 review available for zonisamide and Neurodegenerative Diseases
| Article | Year |
|---|---|
Zonisamide in Parkinson's disease: a current update.
Topics: Dopamine; Humans; Levodopa; Neurodegenerative Diseases; Parkinson Disease; Zonisamide | 2021 |